Get the Stockscreener App
0.00
100.00%
-6.365
Cyclacel Pharmaceuticals Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.
See More
Previous Close:
$6.365
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$15.16M
Revenue:
$74,000
Net Income/Loss:
$-13.43M
P/E Ratio:
0.00
EPS:
-9.4
Net Cash Flow:
$-10.54M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$39.84
Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile
Name
Cyclacel Pharmaceuticals Inc
Sector
Industry
Phone
908-517-7330
Address
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
Compare CYCC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CYCC
Cyclacel Pharmaceuticals Inc
|
0.00 | 15.16M | 74,000 | -13.43M | -10.54M | -9.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.31 | 98.90B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.49 | 58.51B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.70 | 59.77B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
719.04 | 43.55B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.83 | 35.81B | 3.81B | -644.79M | -669.77M | -6.24 |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Apr-27-20 | Resumed | ROTH Capital | Buy |
| Sep-07-18 | Initiated | Ladenburg Thalmann | Buy |
| Oct-16-15 | Initiated | H.C. Wainwright | Buy |
| Feb-04-10 | Initiated | Roth Capital | Buy |
| Oct-28-09 | Initiated | Merriman | Buy |
| Aug-12-08 | Initiated | Piper Jaffray | Buy |
| Mar-12-08 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-12-08 | Reiterated | Collins Stewart | Buy |
| Mar-12-08 | Reiterated | Needham & Co | Buy |
| Nov-27-07 | Reiterated | Cantor Fitzgerald | Buy |
| Aug-10-07 | Reiterated | Cantor Fitzgerald | Buy |
| Jun-04-07 | Reiterated | Needham & Co | Buy |
| Apr-23-07 | Initiated | Lazard Capital | Buy |
| Apr-10-07 | Initiated | Cantor Fitzgerald | Buy |
View All
Cyclacel Pharmaceuticals Inc Stock (CYCC) Latest News
Earnings visualization tools for Cyclacel Pharmaceuticals Inc.July 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
Identifying reversal signals in Cyclacel Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - newser.com
Best data tools to analyze Cyclacel Pharmaceuticals Inc. stockRecession Risk & Consistent Growth Stock Picks - newser.com
Statistical indicators supporting Cyclacel Pharmaceuticals Inc.’s strengthQuarterly Portfolio Report & Proven Capital Preservation Methods - newser.com
Is Cyclacel Pharmaceuticals Inc a good long term investmentRetail Investor Activity & Free Tremendous Portfolio Expansion - earlytimes.in
What drives Cyclacel Pharmaceuticals Inc stock priceFederal Reserve Announcements & Low Risk High Yield - Early Times
Has Cyclacel Pharmaceuticals Inc. found a price floorPortfolio Update Summary & Advanced Swing Trade Entry Plans - newser.com
Heatmap analysis for Cyclacel Pharmaceuticals Inc. and competitorsFed Meeting & High Conviction Trade Alerts - newser.com
Is Cyclacel Pharmaceuticals Inc. showing signs of accumulationCEO Change & Verified Technical Signals - newser.com
Real time pattern detection on Cyclacel Pharmaceuticals Inc. stock2025 Market Overview & Community Consensus Stock Picks - newser.com
Can technical indicators confirm Cyclacel Pharmaceuticals Inc.’s reversalWeekly Stock Recap & Consistent Growth Stock Picks - newser.com
Income Plays: Can Cyclacel Pharmaceuticals Inc reach all time highs this year2025 Retail Activity & Weekly Top Gainers Trade List - خودرو بانک
Is now a turning point for Cyclacel Pharmaceuticals Inc.Quarterly Profit Summary & Smart Money Movement Alerts - newser.com
S P Trends: Does SBRA stock have upside surprise potentialMarket Growth Report & Verified Entry Point Detection - خودرو بانک
Risk Check: Is Cyclacel Pharmaceuticals Inc. stock trending bullishM&A Rumor & Daily Technical Stock Forecast Reports - khodrobank.com
Live market analysis of Cyclacel Pharmaceuticals Inc.July 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
Value Recap: Is Cyclacel Pharmaceuticals Inc gaining market share2025 Dividend Review & AI Based Trade Execution Alerts - خودرو بانک
Cyclacel Pharmaceuticals Inc. stock momentum explained2025 Support & Resistance & Intraday High Probability Setup Alerts - newser.com
Exit Recap: Whats the RSI of Cyclacel Pharmaceuticals Inc stockJuly 2025 Summary & Consistent Return Strategy Ideas - خودرو بانک
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Short Interest Up 49.8% in August - Defense World
Meme Stocks: Can Cyclacel Pharmaceuticals Inc reach all time highs this year2025 Market Sentiment & Weekly High Momentum Picks - خودرو بانک
Published on: 2025-09-17 01:25:53 - newser.com
Will Cyclacel Pharmaceuticals Inc. benefit from macro trends2025 Geopolitical Influence & Long Hold Capital Preservation Plans - newser.com
Cyclacel Pharmaceuticals: Recent Acquisition Completed - MSN
Pullback Watch: Can Cyclacel Pharmaceuticals Inc reach all time highs this year2025 Key Lessons & Long-Term Growth Stock Strategies - خودرو بانک
Cyclacel Pharmaceuticals to implement 1-for-16 reverse stock split; shares fall - MSN
Bio Green Med Solution Faces Nasdaq Delisting Notice - TipRanks
Risks Report: What are Cyclacel Pharmaceuticals Incs earnings expectations2025 Analyst Calls & Growth Focused Stock Pick Reports - خودرو بانک
Aug Swings: What is the Moat Score of Cyclacel Pharmaceuticals IncEarnings Risk Report & Capital Protection Trading Alerts - خودرو بانک
Street Watch: Is Cyclacel Pharmaceuticals Inc a top pick in the sectorRecession Risk & Growth Focused Stock Pick Reports - خودرو بانک
Panic Selling: Is Cyclacel Pharmaceuticals Inc. stock trending bullishLayoff News & Technical Pattern Based Buy Signals - خودرو بانک
Aug Movers: What is the Moat Score of Cyclacel Pharmaceuticals IncEarnings Miss & Short-Term Trading Opportunity Alerts - khodrobank.com
Aug Action: Does Cyclacel Pharmaceuticals Inc have a competitive edge2025 Big Picture & Consistent Growth Stock Picks - خودرو بانک
Earnings Update: What are the risks of holding Cyclacel Pharmaceuticals IncTrade Entry Report & Daily Growth Stock Investment Tips - خودرو بانک
Sentiment Review: What’s the fair value of Cyclacel Pharmaceuticals Inc. stockJuly 2025 Opening Moves & Free Fast Entry Momentum Trade Alerts - خودرو بانک
Risk vs reward if holding onto Cyclacel Pharmaceuticals Inc.Rate Hike & Entry Point Strategy Guides - newser.com
Key metrics from Cyclacel Pharmaceuticals Inc.’s quarterly dataJuly 2025 Short Interest & Proven Capital Preservation Methods - newser.com
Should you hold or exit Cyclacel Pharmaceuticals Inc. nowJuly 2025 Market Mood & Target Return Focused Picks - newser.com
Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd. - The Manila Times
Bio Green Med Solution announces closing of strategic acquisition of Fitters Sdn. Bhd. - MarketScreener
Bio Green Med Solution, Inc. Completes Acquisition of Fitters Sdn. Bhd. to Diversify Business Portfolio - Quiver Quantitative
Cyclacel Pharmaceuticals Inc Stock (CYCC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):